Access cutting-edge nodular lymphocyte-predominant hodgkin lymphoma treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Hackensack location
Preparing your pre-screening questions…
Access nodular lymphocyte-predominant hodgkin lymphoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nodular lymphocyte-predominant hodgkin lymphoma treatment provided free
Check if you qualify for this nodular lymphocyte-predominant hodgkin lymphoma clinical trial in Hackensack, NJ
No-Cost Study Care
Local to Hackensack
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal symptom burden and treatment tolerability utilizing validated patient-reported outcomes (PROs) instruments. Primary Objective: * To develop the data collection infrastructure required to prospectively collect longitudinal electronic patient-reported outcomes (PROs) survey instruments in adult and pediatric patients diagnosed with NLPHL. Secondary Objective: * To examine differences in baseline and longitudinal changes in PROs based on disease characteristics, disease status, and treatment strategies among adult and pediatric patients diagnosed with NLPHL.
Sponsor: St. Jude Children's Research Hospital
Yes, this clinical trial (NCT06098430) has an active research site in Hackensack, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for nodular lymphocyte-predominant hodgkin lymphoma treatment options in Hackensack, NJ, this clinical trial (NCT06098430) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nodular lymphocyte-predominant hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all nodular lymphocyte-predominant hodgkin lymphoma clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in Hackensack — not just this study.
Browse Lymphoma Trials in Hackensack →